Basel, October 19, 2025 – Novartis today presents new Pluvicto™ (lutetium (177Lu) vipivotide tetraxetan) data from the Phase III PSMAddition…
TIANJIN, China, Oct. 16, 2025 /PRNewswire/ -- In response to the robust growth of the electric bicycle markets worldwide, DAHON…
With growing scrutiny around the quality and reliability of generic medicines in India, Medkart, Gujarat’s largest generic-first pharmacy chain, is…
BOSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in threat detection and exposure management, today…
LEUVEN, BELGIUM – BYD has responded to the ’Not Recommended’ grading which Euro NCAP gave to the ATTO 3’s Assisted…
Company also showcases public health and disaster response upfits, highlighting vehicle’s flexibility for municipalities and government agencies of every sizeBROOKLYN,…
INNSBRUCK, Austria, Sept. 22, 2025 /PRNewswire/ -- AV-Comparatives, the leading independent cybersecurity testing lab, today announced the results of its…
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…
MUNICH, Sept. 6, 2025 /PRNewswire/ -- Recently, GAC officially introduced its all-new extended-range technology ADiMOTION, which enhances range extender efficiency, power response,…
New York City, NY, Aug. 30, 2025 (GLOBE NEWSWIRE) -- In response to Ethereum’s historic performance this month, FY Energy is…